Treatments for secondary hyperparathyroidism in hemodialysis

被引：1
作者：
Cozzolino, Mario [1 ]
Messa, Piergiorgio [2 ,3 ]
机构：
[1] Univ Milan, Dept Hlth Sci, Div Renal, ASST Santi Paolo & Carlo, Milan, Italy
[2] Univ Milan, Div Nephrol, Maggiore Hosp, Milan, Italy
[3] Univ Milan, IRCCS Fdn, Milan, Italy
来源：
POLISH ARCHIVES OF INTERNAL MEDICINE-POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ | 2017年 / 127卷 / 12期
关键词：
CHRONIC KIDNEY-DISEASE; PATIENTS RECEIVING HEMODIALYSIS; DISORDER CKD-MBD; VITAMIN-D; CINACALCET; PROGRESSION; DIALYSIS; CALCIUM; TRIAL;
D O I：
10.20452/pamw.4170
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：807 / 809
页数：3
相关论文
共 50 条
[41]   Is cinacalcet a cost-effective treatment in severe secondary hyperparathyroidism in patients on hemodialysis? [J].
Arenas, M. D. ;
Rebollo, P. ;
Alvarez-Ude, F. ;
Prieto, L. ;
Gil, M. T. ;
Malek, T. ;
Moledous, A. ;
Nunez, C. .
NEFROLOGIA, 2008, 28 (05) :511-516
[42]   Effect of cinacalcet on bone mineral density of the radius in hemodialysis patients with secondary hyperparathyroidism [J].
Ishimura, E. ;
Okuno, S. ;
Tsuboniwa, N. ;
Ichii, M. ;
Yamakawa, K. ;
Yamakawa, T. ;
Shoji, S. ;
Nishizawa, Y. ;
Inaba, M. .
CLINICAL NEPHROLOGY, 2011, 76 (04) :259-265
[43]   Once-weekly intravenous paricalcitol in the treatment of secondary hyperparathyroidism in hemodialysis patients [J].
Staniforth, ME ;
Cheng, SC ;
Coyne, DW .
CLINICAL NEPHROLOGY, 2005, 63 (06) :454-460
[44]   Treatment with cinacalcet increases plasma sclerostin concentration in hemodialysis patients with secondary hyperparathyroidism [J].
Kuczera, Piotr ;
Adamczak, Marcin ;
Wiecek, Andrzej .
BMC NEPHROLOGY, 2016, 17 :1-7
[45]   Pharmacological control of secondary hyperparathyroidism in chronic hemodialysis patients: cinacalcet is coming to Japan [J].
Iseki, Kunitoshi .
EXPERT OPINION ON PHARMACOTHERAPY, 2008, 9 (04) :601-610
[46]   Intravenous Alfacalcidol Once Weekly Pulse Therapy for Secondary Hyperparathyroidism in Hemodialysis Patients [J].
El-Shafey, Eid Mohamed ;
Alsahow, Ali Eid ;
El-Nagar, Gamal Fathy ;
Ezzat, Amal .
RENAL FAILURE, 2011, 33 (03) :329-333
[47]   Calcitriol Treatment Attenuates Inflammation and Oxidative Stress in Hemodialysis Patients with Secondary Hyperparathyroidism [J].
Wu, Chia-Chao ;
Chang, Jen-Hung ;
Chen, Chun-Chi ;
Su, Shih-Bin ;
Yang, Lai-King ;
Ma, Wen-Ya ;
Zheng, Cai-Mei ;
Diang, Liang-Kuang ;
Lu, Kuo-Cheng .
TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, 2011, 223 (03) :153-159
[48]   Treatment Based on Cinacalcet Reduces Oxidative Stress in Hemodialysis Patients with Secondary Hyperparathyroidism [J].
Kuczera, Piotr ;
Adamczak, Marcin ;
Machnik, Grzegorz ;
Okopien, Boguslaw ;
Wiecek, Andrzej .
NEPHRON, 2018, 139 (04) :286-292
[49]   Comparative Effectiveness of Alternative Treatment Approaches to Secondary Hyperparathyroidism in Patients Receiving Maintenance Hemodialysis: An Observational Trial Emulation [J].
Platt, Alyssa ;
Wilson, Jonathan ;
Hall, Rasheeda ;
Ephraim, Patti L. ;
Morton, Sarah ;
Shafi, Tariq ;
Weiner, Daniel E. ;
Boulware, L. Ebony ;
Pendergast, Jane ;
Scialla, Julia J. .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2024, 83 (01) :58-70
[50]   Real-World Experience of Using Etelcalcetide for Secondary Hyperparathyroidism in Community-Based Hemodialysis Centers in Singapore [J].
Khan, Behram A. ;
Qu, Xiaojie ;
Hua, Yan ;
Javaid, Muhammad M. .
CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (11)
12345